In this era of precision medicine, with the help of biomarkers, immunotherapy has
significantly improved prognosis of many patients with malignant tumor. Deficient mismatch …

Simple Summary Cholangiocarcinoma (CCA) is a heterogenous and aggressive
malignancy of the intra-and extrahepatic biliary tract, marked by a steeply rising incidence …

This study aims to analyze the efficiency performance of conventional and Islamic rural
banks in Indonesia, specifically, Bank Perkreditan Rakyat (BPR) and Bank Pembiayaan …

Background A therapeutic strategy involving combined treatment with lenvatinib plus
pembrolizumab (LEP) has demonstrated a relatively high antitumor response in several …

Simple Summary Platelet-to-lymphocyte ratio has shown prognostic value in several
malignancies; however, its role in cholangiocarcinoma remains to be determined. Therefore …

Background Cholangiocarcinoma was a highly malignant liver cancer with poor prognosis,
and immune infiltration status was considered an important factor in response to …

The neutrophil-to-lymphocyte ratio (NLR) is used as biomarker in malignant diseases
showing significant association with poor oncological outcomes. The main research …

Cholangiocarcinoma (CCA) is a type of aggressive tumor that involves the intrahepatic,
perihilar and distal biliary tree, and is usually diagnosed at an advanced stage. The …

Poly adenosine diphosphate-ribose polymerase inhibitors (PARPi) represent an effective
therapeutic strategy for cancer patients harboring germline and somatic aberrations in DNA …

Cholangiocarcinoma (CCA) is a rare malignancy with generally dismal prognosis.
Immunotherapy has revolutionized the management of cancer patients during the last …